tofisopam has been researched along with Substance Withdrawal Syndrome in 1 studies
tofisopam: structure; dextofisopam is the R-enantiomer of tofisopam & antidiarrheal
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bánki, CM | 1 |
1 trial available for tofisopam and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Comparative study with Grandaxin and diazepam in alcohol withdrawal syndrome and gerontopsychiatric diseases.
Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dementia; Diazepam; Ethanol; F | 1983 |